Meet Our Experienced Management Team
Our senior leadership team members at Seelos Therapeutics are passionate, empowered, experienced, and committed to building our responsibly-driven company focused on the most efficient development of products that address significant unmet needs in CNS disorders and in rare diseases.
| Raj Mehra, PhD Chairman, Founder, and Chief Executive Officer | 23 years experience as VC/investor |
| Michael Golembiewski Chief Financial Officer | 28 years experience in public company accounting and finance |
| Tim Whitaker, MD Chief Medical Officer | 24 years experience with 19 NDAs and sNDAs approved in CNS |
| Warren Wasiewski, MD Senior Neuro Advisor | 23 years of experience as pediatric neurologist, 18 years in pharma industry, and designed clinical trials for 5 orphan CNS programs |
| Karen Fusaro SVP Head of Clinical Operations | 27 years experience with 4 NDAs in infectious diseases |
| Gopal Krishna, PhD Head of Manufacturing &Technical Operations | 27 years experience in cGMP, GLP, and CMC regulations |
| Anthony Marciano Chief Communications Officer | 25 years experience in Healthcare Investor Engagement |
Meet Our Board of Directors
Our Board of Directors has each established their leadership in the industry. Raj Mehra, Ph.D., Chairman, founder, and CEO of Seelos will serve as the Chairman, CEO, and President. Dr. Mehra is joined by Richard Pascoe, CEO, KemPharm, Inc.; Margaret Dalesandro, PhD, Founder and President, Brecon Pharma Consulting LLC.; Daniel J. O’Connor, CEO of Ambrx Biopharma, Inc.; and Brian Lian, Ph.D., CEO and President of Viking Therapeutics, Inc. Each assist Seelos management in our strategic planning and ensures sound decision-making regarding our goals for the short- and long-term. They review, understand, and help ensure that Seelos has the right plans, the right people, and an optimized pipeline to help us progress towards the achievement of our objectives and to build shareholder value.
| Raj Mehra, PhD | Chairman, Founder, and Chief Executive Officer, Seelos Therapeutics, Inc. |
| Richard Pascoe | CEO, KemPharm, Inc. |
| Margaret Dalesandro, PhD | Founder and President, Brecon Pharma Consulting, LLC |
| Daniel J. O’Connor | Chief Executive Officer of Ambrx Biopharma, Inc. |
| Brian Lian, PhD | CEO and President, Viking Therapeutics, Inc. |
Please review our Privacy Policy, Terms of Use, and Accessibility information located at the bottom of this page.